DMAC2
gene geneOn this page
Also known as FLJ10241
Summary
DMAC2 (distal membrane arm assembly component 2, HGNC:25496) is a protein-coding gene on chromosome 19q13.2, encoding Distal membrane-arm assembly complex protein 2 (Q9NW81). Required for the assembly of the mitochondrial NADH:ubiquinone oxidoreductase complex (complex I).
Involved in mitochondrial respiratory chain complex I assembly. Located in mitochondrion.
Source: NCBI Gene 55101 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 65 total
- MANE Select transcript:
NM_018035
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25496 |
| Approved symbol | DMAC2 |
| Name | distal membrane arm assembly component 2 |
| Location | 19q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10241 |
| Ensembl gene | ENSG00000105341 |
| Ensembl biotype | protein_coding |
| OMIM | 617262 |
| Entrez | 55101 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 12 protein_coding, 3 retained_intron, 1 nonsense_mediated_decay
ENST00000221943, ENST00000301183, ENST00000417807, ENST00000438807, ENST00000586786, ENST00000589102, ENST00000589503, ENST00000589970, ENST00000590641, ENST00000592922, ENST00000594339, ENST00000594660, ENST00000595407, ENST00000595425, ENST00000597457, ENST00000597608
RefSeq mRNA: 11 — MANE Select: NM_018035
NM_001167867, NM_001167868, NM_001167869, NM_001167870, NM_001167871, NM_001320838, NM_001320839, NM_001320840, NM_001320841, NM_001320844, NM_018035
CCDS: CCDS33032, CCDS54269, CCDS54270, CCDS54271, CCDS59389, CCDS59390, CCDS82353, CCDS82354
Canonical transcript exons
ENST00000221943 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000708457 | 41433272 | 41433434 |
| ENSE00002748963 | 41431318 | 41432408 |
| ENSE00003495250 | 41438218 | 41438414 |
| ENSE00003574808 | 41433537 | 41433673 |
| ENSE00003593721 | 41436392 | 41436472 |
| ENSE00003899942 | 41439882 | 41439912 |
Expression profiles
Bgee: expression breadth ubiquitous, 290 present calls, max score 97.58.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.9457 / max 175.6751, expressed in 1811 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 181068 | 15.3724 | 1811 |
| 181067 | 0.5408 | 283 |
| 181066 | 0.0325 | 9 |
Top tissues by expression
292 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 97.58 | gold quality |
| heart left ventricle | UBERON:0002084 | 97.01 | gold quality |
| cardiac ventricle | UBERON:0002082 | 96.95 | gold quality |
| jejunal mucosa | UBERON:0000399 | 95.91 | gold quality |
| parotid gland | UBERON:0001831 | 95.88 | gold quality |
| heart | UBERON:0000948 | 95.45 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.84 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 94.78 | gold quality |
| heart right ventricle | UBERON:0002080 | 94.76 | gold quality |
| duodenum | UBERON:0002114 | 94.70 | gold quality |
| cardiac atrium | UBERON:0002081 | 94.64 | gold quality |
| diaphragm | UBERON:0001103 | 94.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 94.26 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.22 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 94.17 | gold quality |
| lower esophagus | UBERON:0013473 | 94.16 | gold quality |
| biceps brachii | UBERON:0001507 | 93.98 | gold quality |
| vastus lateralis | UBERON:0001379 | 93.83 | gold quality |
| muscle of leg | UBERON:0001383 | 93.80 | gold quality |
| quadriceps femoris | UBERON:0001377 | 93.75 | gold quality |
| muscle organ | UBERON:0001630 | 93.70 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 93.70 | gold quality |
| jejunum | UBERON:0002115 | 93.46 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 93.46 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 93.45 | gold quality |
| embryo | UBERON:0000922 | 93.40 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 93.29 | gold quality |
| myocardium | UBERON:0002349 | 93.26 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 93.15 | gold quality |
| ganglionic eminence | UBERON:0004023 | 93.14 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.07 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
37 targeting DMAC2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-3153 | 99.55 | 67.59 | 2337 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-4786-3P | 99.36 | 68.35 | 1390 |
| HSA-MIR-6128 | 99.33 | 67.83 | 1581 |
| HSA-MIR-6828-5P | 99.31 | 69.21 | 1433 |
| HSA-MIR-4721 | 99.26 | 66.05 | 818 |
| HSA-MIR-5589-5P | 98.34 | 64.82 | 1148 |
| HSA-MIR-653-3P | 98.31 | 67.71 | 1542 |
| HSA-MIR-4664-5P | 98.17 | 65.07 | 1020 |
| HSA-MIR-892B | 98.00 | 67.11 | 821 |
| HSA-MIR-6819-5P | 97.96 | 66.59 | 1071 |
| HSA-MIR-4446-3P | 97.91 | 64.29 | 991 |
| HSA-MIR-146B-3P | 97.83 | 65.29 | 782 |
| HSA-MIR-6737-5P | 97.75 | 66.54 | 1044 |
| HSA-MIR-634 | 97.74 | 67.11 | 818 |
| HSA-MIR-6812-5P | 97.56 | 65.39 | 1059 |
| HSA-MIR-342-5P | 97.25 | 64.10 | 817 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dmac2 | ENSDARG00000096597 |
| mus_musculus | Dmac2 | ENSMUSG00000057229 |
| rattus_norvegicus | Dmac2 | ENSRNOG00000020596 |
| drosophila_melanogaster | CG4042 | FBGN0037018 |
| caenorhabditis_elegans | WBGENE00021815 |
Protein
Protein identifiers
Distal membrane-arm assembly complex protein 2 — Q9NW81 (reviewed: Q9NW81)
Alternative names: ATP synthase subunit s-like protein
All UniProt accessions (8): Q9NW81, B4DFT4, K7EIV4, K7ESN5, M0QX81, M0QZC4, M0QZP7, M0R078
UniProt curated annotations — full annotation on UniProt →
Function. Required for the assembly of the mitochondrial NADH:ubiquinone oxidoreductase complex (complex I). Involved in the assembly of the distal region of complex I.
Subunit / interactions. Interacts with incompletely assembled mitochondrial NADH:ubiquinone oxidoreductase complex (complex I).
Subcellular location. Mitochondrion.
Similarity. Belongs to the ATP synthase subunit s family.
Isoforms (6)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NW81-1 | 1 | yes |
| Q9NW81-2 | 2 | |
| Q9NW81-3 | 3 | |
| Q9NW81-4 | 4 | |
| Q9NW81-5 | 5 | |
| Q9NW81-6 | 6 |
RefSeq proteins (11): NP_001161339, NP_001161340, NP_001161341, NP_001161342, NP_001161343, NP_001307767, NP_001307768, NP_001307769, NP_001307770, NP_001307773, NP_060505* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
UniProt features (11 total): sequence variant 5, splice variant 3, chain 1, modified residue 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NW81-F1 | 79.56 | 0.63 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 253
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6799198 | Complex I biogenesis |
MSigDB gene sets: 107 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, MCBRYAN_PUBERTAL_BREAST_4_5WK_DN, MCBRYAN_PUBERTAL_BREAST_5_6WK_UP, GOBP_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS, NOUZOVA_TRETINOIN_AND_H4_ACETYLATION, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, GOBP_PROTEIN_CATABOLIC_PROCESS, SENESE_HDAC3_TARGETS_DN, GOCC_SCF_UBIQUITIN_LIGASE_COMPLEX, NUYTTEN_EZH2_TARGETS_DN
GO Biological Process (2): SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146), mitochondrial respiratory chain complex I assembly (GO:0032981)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): mitochondrion (GO:0005739), SCF ubiquitin ligase complex (GO:0019005)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Respiratory electron transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| proteasome-mediated ubiquitin-dependent protein catabolic process | 1 |
| NADH dehydrogenase complex assembly | 1 |
| mitochondrial respiratory chain complex assembly | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| cullin-RING ubiquitin ligase complex | 1 |
Protein interactions and networks
STRING
734 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DMAC2 | FOXRED1 | Q96CU9 | 835 |
| DMAC2 | TMEM70 | Q9BUB7 | 796 |
| DMAC2 | DMAC1 | Q96GE9 | 733 |
| DMAC2 | TMEM186 | Q96B77 | 715 |
| DMAC2 | TTC9B | Q8N6N2 | 611 |
| DMAC2 | TIMMDC1 | Q9NPL8 | 550 |
| DMAC2 | TMEM126B | Q8IUX1 | 520 |
| DMAC2 | IRGQ | Q8WZA9 | 520 |
| DMAC2 | NDUFAF1 | Q9Y375 | 511 |
| DMAC2 | NDUFB11 | Q9NX14 | 506 |
| DMAC2 | NDUFAF4 | Q9P032 | 502 |
| DMAC2 | NDUFB10 | O96000 | 501 |
| DMAC2 | NDUFB1 | O75438 | 497 |
| DMAC2 | OXA1L | Q15070 | 493 |
| DMAC2 | NDUFB6 | O95139 | 481 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RCCD1 | SPAG9 | psi-mi:“MI:0914”(association) | 0.640 |
| SLC15A3 | psi-mi:“MI:0914”(association) | 0.350 | |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| MGARP | BTAF1 | psi-mi:“MI:0914”(association) | 0.350 |
| AFG2A | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| AFG2B | MMP24OS | psi-mi:“MI:0914”(association) | 0.350 |
| FECH | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| CELA3A | PIK3C2A | psi-mi:“MI:0914”(association) | 0.350 |
| SLC39A2 | AGPAT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (17): ATP5SL (Affinity Capture-RNA), ATP5SL (Affinity Capture-RNA), ATP5SL (Affinity Capture-RNA), ATP5SL (Affinity Capture-MS), ATP5SL (Affinity Capture-MS), ATP5SL (Affinity Capture-MS), ATP5SL (Affinity Capture-MS), ATP5SL (Affinity Capture-MS), ATP5SL (Positive Genetic), ATP5SL (Affinity Capture-RNA), ATP5SL (Affinity Capture-MS), ATP5SL (Affinity Capture-MS), ATP5SL (Affinity Capture-MS), ATP5SL (Affinity Capture-MS), ATP5SL (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A1B0GU71, A6QPI4, B2RV13, D4A6L0, E1BBQ2, F1LQY6, G3UW36, O08856, P15382, P53801, P55199, P56182, Q08CB3, Q0VF94, Q148E1, Q17RQ9, Q2KJ58, Q32Q90, Q4R5F9, Q4V8A6, Q4VA36, Q5I0I4, Q5NVI6, Q5R8Q2, Q5T6X4, Q5T848, Q5XII8, Q68EN5, Q6P767, Q8C419, Q8CHT6, Q8R143, Q8R1T1, Q8TBN0, Q8VDV3, Q8WUX9, Q90YH8, Q91WM6, Q91ZP9, Q96IL0
Diamond homologs: A6QNS9, Q4R5F9, Q5I0I4, Q9D7K5, Q9NW81, Q9VPC1, P22027, Q4R5S4, Q5R9E6, Q5XIM4, Q99766, Q9CRA7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
65 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 12 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
959 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:41432944:AGCTT:A | donor_gain | 1.0000 |
| 19:41432948:T:TA | donor_gain | 1.0000 |
| 19:41433202:T:TA | donor_gain | 1.0000 |
| 19:41433270:A:AC | donor_gain | 1.0000 |
| 19:41433271:C:CC | donor_gain | 1.0000 |
| 19:41433335:T:TA | donor_gain | 1.0000 |
| 19:41433535:A:AC | donor_gain | 1.0000 |
| 19:41433536:C:CT | donor_gain | 1.0000 |
| 19:41433536:CGG:C | donor_gain | 1.0000 |
| 19:41433536:CGGA:C | donor_gain | 1.0000 |
| 19:41433536:CGGAG:C | donor_gain | 1.0000 |
| 19:41433669:GAAAC:G | acceptor_gain | 1.0000 |
| 19:41433670:AAAC:A | acceptor_gain | 1.0000 |
| 19:41433671:AAC:A | acceptor_gain | 1.0000 |
| 19:41433672:AC:A | acceptor_gain | 1.0000 |
| 19:41433673:CC:C | acceptor_gain | 1.0000 |
| 19:41433674:C:CC | acceptor_gain | 1.0000 |
| 19:41433674:C:T | acceptor_gain | 1.0000 |
| 19:41433674:CT:C | acceptor_loss | 1.0000 |
| 19:41433681:C:CT | acceptor_gain | 1.0000 |
| 19:41433682:G:T | acceptor_gain | 1.0000 |
| 19:41436382:G:C | donor_gain | 1.0000 |
| 19:41436390:A:AC | donor_gain | 1.0000 |
| 19:41436391:C:CC | donor_gain | 1.0000 |
| 19:41436391:CTTGA:C | donor_gain | 1.0000 |
| 19:41436404:C:A | donor_gain | 1.0000 |
| 19:41438415:C:CC | acceptor_gain | 1.0000 |
| 19:41432945:G:C | donor_gain | 0.9900 |
| 19:41432969:G:C | donor_gain | 0.9900 |
| 19:41433207:T:A | donor_gain | 0.9900 |
AlphaMissense
1673 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:41433670:A:C | F100L | 0.985 |
| 19:41433670:A:T | F100L | 0.985 |
| 19:41433672:A:G | F100L | 0.985 |
| 19:41433588:C:G | A128P | 0.980 |
| 19:41433341:A:G | L176S | 0.976 |
| 19:41436395:A:T | V98D | 0.976 |
| 19:41433657:A:G | W105R | 0.975 |
| 19:41433657:A:T | W105R | 0.975 |
| 19:41433671:A:G | F100S | 0.972 |
| 19:41433332:A:T | L179H | 0.971 |
| 19:41433318:A:G | C184R | 0.969 |
| 19:41433655:C:A | W105C | 0.969 |
| 19:41433655:C:G | W105C | 0.969 |
| 19:41432318:G:C | C229W | 0.967 |
| 19:41433332:A:G | L179P | 0.967 |
| 19:41436418:G:C | F90L | 0.967 |
| 19:41436418:G:T | F90L | 0.967 |
| 19:41436420:A:G | F90L | 0.967 |
| 19:41433410:A:G | L153S | 0.966 |
| 19:41432319:C:T | C229Y | 0.965 |
| 19:41433593:A:T | V126D | 0.965 |
| 19:41432346:A:G | I220T | 0.959 |
| 19:41432403:A:T | L201H | 0.958 |
| 19:41433375:A:G | C165R | 0.958 |
| 19:41433297:C:G | G191R | 0.957 |
| 19:41433293:A:T | L192H | 0.956 |
| 19:41433371:A:T | L166H | 0.953 |
| 19:41433419:A:T | L150H | 0.952 |
| 19:41433552:C:G | G140R | 0.952 |
| 19:41433284:A:T | L195H | 0.951 |
dbSNP variants (sampled 300 via entrez): RS1000173416 (19:41440070 G>A,C), RS1000399431 (19:41434106 G>A), RS1000673815 (19:41439809 C>T), RS1000798840 (19:41434478 A>G), RS1001221550 (19:41441427 C>G), RS1001390746 (19:41435469 C>T), RS1001569491 (19:41441599 G>T), RS1002961129 (19:41432326 G>A), RS1003286069 (19:41431486 C>T), RS1004511517 (19:41441114 C>G), RS1004555358 (19:41431438 G>A), RS1004641609 (19:41435120 C>T), RS1004766526 (19:41436566 C>G), RS1006867505 (19:41434785 A>G), RS1007204864 (19:41433512 C>A,G)
Disease associations
OMIM: gene MIM:617262 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000817_179 | Height | 5.000000e-16 |
| GCST001119_2 | Schizophrenia | 1.000000e-07 |
| GCST001714_1 | Prostate cancer | 1.000000e-08 |
| GCST001714_2 | Prostate cancer | 2.000000e-12 |
| GCST008163_545 | Height | 4.000000e-10 |
| GCST012227_1353 | Hip circumference adjusted for BMI | 6.000000e-11 |
| GCST90020028_1331 | Hip circumference adjusted for BMI | 4.000000e-10 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 2 |
| arsenite | affects binding, increases reaction | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, decreases expression | 1 |
| Lead | affects splicing | 1 |
| Smoke | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1Q6 | Abcam HeLa DMAC2 KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.